Cargando…

Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—An observational cohort study

The goal of this study was to assess the adherence of primary open-angle glaucoma (POAG) patients to medication, and to determine co-factors influencing adherence, using a representative sample of members of the largest German public health insurer. The observational cohort study was based on a long...

Descripción completa

Detalles Bibliográficos
Autores principales: Frech, Stefanie, Kreft, Daniel, Guthoff, Rudolf F., Doblhammer, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766149/
https://www.ncbi.nlm.nih.gov/pubmed/29329338
http://dx.doi.org/10.1371/journal.pone.0191185
_version_ 1783292324269260800
author Frech, Stefanie
Kreft, Daniel
Guthoff, Rudolf F.
Doblhammer, Gabriele
author_facet Frech, Stefanie
Kreft, Daniel
Guthoff, Rudolf F.
Doblhammer, Gabriele
author_sort Frech, Stefanie
collection PubMed
description The goal of this study was to assess the adherence of primary open-angle glaucoma (POAG) patients to medication, and to determine co-factors influencing adherence, using a representative sample of members of the largest German public health insurer. The observational cohort study was based on a longitudinal data set from 2010–2013 and included 250,000 insured persons aged 50 and older with 10,120 diagnosed POAG patients. Uni- and multivariate analysis was performed to investigate several aspects of glaucoma, such as prevalence, adherence, and co-factors influencing adherence. The main outcome measured adherence with prescriptions filled within a year. Multivariate panel regression analysis was used to determine the co-factors influencing this adherence. Prevalence of POAG was 3.36% [CI: 3.28–3.43%], with 2.91% [CI: 2.81–3.01%] for males and 3.71% [CI: 3.61–3.81%] for females, increasing with age. The mean level of adherence in terms of prescriptions filled was 66.5% [CI: 65.50–67.60%]. The results of this analysis revealed a significant influence of age, duration of the disease, care need, distance to death, and multimorbidity as co-factors of non-adherence, whereas gender had no influence. The analysis provided detailed information about POAG health care aspects concerning prevalence and adherence. The most endangered risk groups for non-adherence were patients aged 50–59, patients older than 80 years, patients with a longer duration of POAG, patients with care needs, and patients with three or more severe diseases in addition to glaucoma. To know the predictors responsible for an increased risk to develop POAG is of importance for all persons involved in health care management. Therefore effective strategies to increase awareness of patients and medical care personnel about non-adherence and the importance of a regular and continuous medication to avoid further nerve fiber damage and possible blindness have to be developed.
format Online
Article
Text
id pubmed-5766149
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57661492018-01-23 Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—An observational cohort study Frech, Stefanie Kreft, Daniel Guthoff, Rudolf F. Doblhammer, Gabriele PLoS One Research Article The goal of this study was to assess the adherence of primary open-angle glaucoma (POAG) patients to medication, and to determine co-factors influencing adherence, using a representative sample of members of the largest German public health insurer. The observational cohort study was based on a longitudinal data set from 2010–2013 and included 250,000 insured persons aged 50 and older with 10,120 diagnosed POAG patients. Uni- and multivariate analysis was performed to investigate several aspects of glaucoma, such as prevalence, adherence, and co-factors influencing adherence. The main outcome measured adherence with prescriptions filled within a year. Multivariate panel regression analysis was used to determine the co-factors influencing this adherence. Prevalence of POAG was 3.36% [CI: 3.28–3.43%], with 2.91% [CI: 2.81–3.01%] for males and 3.71% [CI: 3.61–3.81%] for females, increasing with age. The mean level of adherence in terms of prescriptions filled was 66.5% [CI: 65.50–67.60%]. The results of this analysis revealed a significant influence of age, duration of the disease, care need, distance to death, and multimorbidity as co-factors of non-adherence, whereas gender had no influence. The analysis provided detailed information about POAG health care aspects concerning prevalence and adherence. The most endangered risk groups for non-adherence were patients aged 50–59, patients older than 80 years, patients with a longer duration of POAG, patients with care needs, and patients with three or more severe diseases in addition to glaucoma. To know the predictors responsible for an increased risk to develop POAG is of importance for all persons involved in health care management. Therefore effective strategies to increase awareness of patients and medical care personnel about non-adherence and the importance of a regular and continuous medication to avoid further nerve fiber damage and possible blindness have to be developed. Public Library of Science 2018-01-12 /pmc/articles/PMC5766149/ /pubmed/29329338 http://dx.doi.org/10.1371/journal.pone.0191185 Text en © 2018 Frech et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Frech, Stefanie
Kreft, Daniel
Guthoff, Rudolf F.
Doblhammer, Gabriele
Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—An observational cohort study
title Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—An observational cohort study
title_full Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—An observational cohort study
title_fullStr Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—An observational cohort study
title_full_unstemmed Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—An observational cohort study
title_short Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—An observational cohort study
title_sort pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—an observational cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766149/
https://www.ncbi.nlm.nih.gov/pubmed/29329338
http://dx.doi.org/10.1371/journal.pone.0191185
work_keys_str_mv AT frechstefanie pharmacoepidemiologicalassessmentofadherenceandinfluencingcofactorsamongprimaryopenangleglaucomapatientsanobservationalcohortstudy
AT kreftdaniel pharmacoepidemiologicalassessmentofadherenceandinfluencingcofactorsamongprimaryopenangleglaucomapatientsanobservationalcohortstudy
AT guthoffrudolff pharmacoepidemiologicalassessmentofadherenceandinfluencingcofactorsamongprimaryopenangleglaucomapatientsanobservationalcohortstudy
AT doblhammergabriele pharmacoepidemiologicalassessmentofadherenceandinfluencingcofactorsamongprimaryopenangleglaucomapatientsanobservationalcohortstudy